Clinical Trial Update: MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing MK-7625A to meropenem in pediatric patients with complicated urinary tract infection; study completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• MK-7625A
• Meropenem (Meropenem)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Complicated Urinary Tract Infection, Pyelonephritis | Phase 2 | Status: COMPLETED | Results posted: 2021-12-01